National Cancer Institute
Posted Date: Aug 23, 2007
Note: A separate PDQ® summary on Adult Non-Hodgkin Lymphoma Treatment is also available.
Since non-Hodgkin lymphomas (NHL) occur in an older patient population than Hodgkin lymphoma, this may account for fewer reports of NHL patients with coexisting pregnancy. 1
Magnetic resonance imaging is the preferred tool for staging evaluation to avoid exposure to ionizing radiation. 1
- Nicklas AH, Baker ME: Imaging strategies in the pregnant cancer patient. Semin Oncol 27 (6): 623-32, 2000. [PUBMED Abstract]
Most non-Hodgkin lymphomas (NHL) are aggressive and delay of therapy until after delivery appears to have poor outcomes according to anecdotal case series. 1 2 3 4 Consequently, some investigators favor immediate therapy, even during pregnancy. 4
Children exposed to high-dose doxorubicin-containing combination chemotherapy in utero (especially during the second and third trimester) have been found to be normal subsequently, with follow-up ranging from several months to 11 years. 4 5 6 7 There are no data regarding long-term effects on children exposed in utero for most of the chemotherapeutic agents used for treatment of NHL.
Termination of pregnancy in the first trimester may be an option to allow therapy for women with aggressive NHL. For some women, early delivery when feasible may minimize or avoid exposure to chemotherapy or radiation therapy. Treatment may be delayed for those women with an indolent NHL.
The designations in PDQ® that treatments are standard or under clinical evaluation are not to be used as a basis for reimbursement determinations.
- Ward FT, Weiss RB: Lymphoma and pregnancy. Semin Oncol 16 (5): 397-409, 1989. [PUBMED Abstract]
- Steiner-Salz D, Yahalom J, Samuelov A, et al.: Non-Hodgkin's lymphoma associated with pregnancy. A report of six cases, with a review of the literature. Cancer 56 (8): 2087-91, 1985. [PUBMED Abstract]
- Spitzer M, Citron M, Ilardi CF, et al.: Non-Hodgkin's lymphoma during pregnancy. Gynecol Oncol 43 (3): 309-12, 1991. [PUBMED Abstract]
- Gelb AB, van de Rijn M, Warnke RA, et al.: Pregnancy-associated lymphomas. A clinicopathologic study. Cancer 78 (2): 304-10, 1996. [PUBMED Abstract]
- Avilés A, Díaz-Maqueo JC, Torras V, et al.: Non-Hodgkin's lymphomas and pregnancy: presentation of 16 cases. Gynecol Oncol 37 (3): 335-7, 1990. [PUBMED Abstract]
- Moore DT, Taslimi MM: Multi-agent chemotherapy in a case of non-Hodgkin's lymphoma in second trimester of pregnancy. J Tenn Med Assoc 84 (9): 435-6, 1991. [PUBMED Abstract]
- Nantel S, Parboosingh J, Poon MC: Treatment of an aggressive non-Hodgkin's lymphoma during pregnancy with MACOP-B chemotherapy. Med Pediatr Oncol 18 (2): 143-5, 1990. [PUBMED Abstract]
The PDQ® cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Editorial changes were made to this summary.
- PDQ® - NCI's Comprehensive Cancer Database.
- Full description of the NCI PDQ® database.
- PDQ® Cancer Information Summaries: Adult Treatment
- Treatment options for adult cancers.
- PDQ® Cancer Information Summaries: Pediatric Treatment
- Treatment options for childhood cancers.
- PDQ® Cancer Information Summaries: Supportive Care
- Side effects of cancer treatment, management of cancer-related complications and pain, and psychosocial concerns.
- PDQ® Cancer Information Summaries: Screening/Detection (Testing for Cancer)
- Tests or procedures that detect specific types of cancer.
- PDQ® Cancer Information Summaries: Prevention
- Risk factors and methods to increase chances of preventing specific types of cancer.
- PDQ® Cancer Information Summaries: Genetics
- Genetics of specific cancers and inherited cancer syndromes, and ethical, legal, and social concerns.
- PDQ® Cancer Information Summaries: Complementary and Alternative Medicine
- Information about complementary and alternative forms of treatment for patients with cancer.
This information is intended mainly for use by doctors and other health care professionals. If you have questions about this topic, you can ask your doctor, or call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237).
October 30, 2014
April 28, 2016